Article ; Online: Gepirone-the latest antidepressant on market state-of-the-art or run-of-the-mill?
2024 Volume 94, Page(s) 103937
Abstract: Gepirone was recently launched and FDA-approved for MDD. It belongs to azapirones group of psychotropics that is in popular use in Japan and China. Here, author wraps up current knowledge on gepirone contrasted with the older and cheaper anxiolytic ... ...
Abstract | Gepirone was recently launched and FDA-approved for MDD. It belongs to azapirones group of psychotropics that is in popular use in Japan and China. Here, author wraps up current knowledge on gepirone contrasted with the older and cheaper anxiolytic buspirone. |
---|---|
MeSH term(s) | Humans ; Pyrimidines ; Buspirone ; Anti-Anxiety Agents/pharmacology ; Anti-Anxiety Agents/therapeutic use ; Antidepressive Agents/pharmacology ; Antidepressive Agents/therapeutic use |
Chemical Substances | gepirone (JW5Y7B8Z18) ; Pyrimidines ; Buspirone (TK65WKS8HL) ; Anti-Anxiety Agents ; Antidepressive Agents |
Language | English |
Publishing date | 2024-02-03 |
Publishing country | Netherlands |
Document type | Letter |
ZDB-ID | 2456678-0 |
ISSN | 1876-2026 ; 1876-2018 |
ISSN (online) | 1876-2026 |
ISSN | 1876-2018 |
DOI | 10.1016/j.ajp.2024.103937 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.